Net Savings Link Inc (OTCMKTS:NSAV) Is Today's Cannabis Focus

Are you a Cannabis trader, profiting from the legalization of the medical marijuana in the United States and Canada? Yes; then you must be interested in the following profile; Net Savings Link, Inc. (OTC:NSAV). The company recently announced its Cannabis Grow Operation Plan in a presentation to investors that you can find here. Traders pushed up the company's share price following this communication and some others. Hence, we believed that a piece was necessary to assess this communication. Have a look at the jump:SourceBusiness history of Net Savings LinkThe company was incorporated under the State of Nevada as Calibert Explorations, Ltd. on February 21, 2007. It became Net Savings Link, Inc. on November 11, 2010. The company is headquartered in Port Jefferson, New York.On June 18, 2014, Net Savings, the company, signed a Share Exchange Agreement with Global Distribution Inc. Under this agreement, Steven Baritz, sole shareholder of GDI, acquired all the issued and outstanding shares of Series A preferred stock from the previous directors. The shares of Series A preferred stock have 1,000 votes each and represented approximately 89% of NSAV's voting power. Mr. Baritz was automatically appointed to the Board of Directors and consequently appointed as president. The company operated a different business at that time, which was not related to the profitable Cannabis sector.Shareholders needed to wait until March 13, 2017 to see that the company entered into the medical cannabis technology business. On that date, it was announced that NSAV intended to provide solutions to the medical cannabis industry along with a wide range of services, such as software solutions, e-commerce, financial services, patents, trademarks, and information technology. On April 26, 2017, the company announced the launch of its corporate website: http://netsavlink.com. We visited it and saw that the business plan is quite ambitious. NSAV is trying to enter into the legal cannabis industry, which is a market of $3.2 billion, in order to target a wide range of problems, such as cancer, epilepsy, and depression, suffered by 1.2 million people.Share Reduction and 10% dividendPart of the explanation of the recent turnaround of the company's share price is the reduction of shares. Shareholders were also told on March 17, 2017 that the company was not planning a reverse split of its shares. Have a look:

• March 21, 2017: major reduction of its authorized shares to be disclosed.
• March 28, 2017: 3.0 billion shares reduction that had been pledged to KBM Worldwide in a settlement negotiated by the Company’s previous management.
• April 7, 2017: 1.5 billion reduction of its authorized shares (40% of the Company’s authorized shares).

For those who don't understand what's going on, a reduction of shares means that the current shareholders are richer, because the percentage of the company owned by each stockholder has increased. That is the reason that right after this news the share price increased.Additionally, on March 31, 2017, the company released a 10% dividend paid via company's shares. The dividend was distributed depending on the percentage of ownership in NSAV. The company said that the company was not diluting shareholders with this operation:

"The dividend will be a share dividend and will be evenly distributed to the shareholders depending on their percentage of ownership in NSAV. This will ensure that there is no dilution to any NSAV shareholder. The Company will announce the record date and other details of the dividend in the coming weeks." Source

No dilution; yes. But, we don't understand why the company reduces capital and some days later decides to pay back a 10% dividend using its own shares. The company did not dilute its shareholders, but made the share price fall because of this transaction. In any case, shareholders gained ownership in the company.The company bought Chinese medical software company, Shanghai Hua Si TaiThe company is quite new, but it seems that the executives are experienced and are making some savvy moves. On April 4, 2017, it announced the acquisition of Shanghai Hua Si Tai, a renowned Chinese medical software company, according to the press release:

"Shanghai Hua Si Tai Company, which owns and operates Shanghai based Vital Strategic Research Institute (VSRI). VSRI is a medical research firm with a long history of expertise in design, clinical trials and global research. The Company sees VSRI as a major opportunity in the world’s largest country and second largest market." Source

The acquisition price was not disclosed, but we can obtain an idea by looking at the financial results of this company, which were released a few days later:

• Net profit: $ 165,000.
• Operating income: $ 690,000

The fact that the company wants to enter the Chinese market should be seen as a good fact. We mentioned that the company has very ambitious plans. Well, this decision is very ambitious too. The Chinese market is substantial and is growing at a higher pace. Thus, entering this market will increase the top line of the group in the near future.Cannabis Grow Operation PlanAs mentioned earlier, the company announced its growth operation plan on May 1, 2017. It will be located in the Poconos region of Pennsylvania, close to NY. It is a smart move as the use of medical marijuana was legalized very recently in Pennsylvania. Some of the following words were said by James Tilton, president of NSAV, and resumed very well the key objectives of the plan:

"I am truly proud of our team and the work that they did to put together such a thorough and complete Marijuana Grow Operation Plan. Medical Cannabis operators from all over the country are trying to set up operations in the Poconos and our presence there certainly gives us a major advantage." Source

In addition, the business executive noted the effect the announcement had on social media:

"On behalf of myself and the entire NSAV team, we wish to thank all of the Company's shareholders for their extremely positive emails and Tweets regarding our newly launched corporate website. It is greatly appreciated." Source

Investors can learn the cash flow projections of the plan here. To cut a long story short, the plan includes a 20,000 square feet cultivation facility and 7,500 square feet for processing and research and development.The company needs to present its financial statementsThere is something that we did not appreciate in this company. The last 10-Q presented was on July 20, 2015. We believe that if the company wants to receive investments from the big boys, then these documents will need to be filed. Savvy traders may see this as a catalyst. Why? If the company shows its current financial statements, more investors will become interested and the share price may increase even more.ConclusionNet Savings Link has very ambitious plans. The management team is acquiring new businesses, reducing the shares outstanding; operating in growing sectors, such as the Cannabis industry, and expanding in growing countries such as China. Honestly, these plans seem promising. Hence, we believe that traders believe in the project and are pushing up the shares because of it. However, readers should be careful as the company had not presented its financial statements yet, thus we need to be cautious, even if this may be a catalyst down the road for the stock. We will keep informing subscribers as we get more information about this company. We will be updating our subscribers as soon as we know more. For the latest updates on NSAV, sign up below.Disclosure: We have no position in NSAV and have not been compensated for this article.